Low bioactive yield recovery: NaturaRecent Research Landscape
Bioactive molecules like peptides and glucosamine often suffer from poor absorption or degradation before reaching systemic circulation. Overcoming these delivery barriers ensures therapeutic efficacy and reduces dosage requirements.